It also will be important to continue to assess the association between GLP-1 use and cancer risk as GLP-1s become more effective, he added
"Best quality, customer first" is what we insist on, and sincerely look forward to establishing long-term and mutually beneficial business relationships with customers worldwide
Pancreatitis and pancreatic cancer Despite the current guidelines against individuals with a history of pancreatic cancer or pre-existing pancreatic conditions, theres no strong evidence that semaglutide, or other GLP-1 medications, increases the risk of pancreatitis, pancreatic cancer or other pancreas-related conditions
DLD ) (5, 53, 54)
Memorial Sloan Kettering Cancer Center
Clinical trial data from the SUSTAIN and STEP programs, which enrolled thousands of participants across multiple countries, did not identify UTIs as a significant adverse event